Abstract: An image forming apparatus includes: an image bearing member; an electrostatic image forming unit; a developing device; an intermediary transfer member; a rotatable transfer member; a constant-voltage element; a power source; a cleaning device; an executing portion capable of executing a toner image collecting mode after jam clearance; and a controller for controlling said power source in the operation in the collecting mode so that a voltage of an identical polarity to a charge polarity of the toner is applied to the rotatable transfer member to transfer, onto the intermediary transfer member, the toner in an upstream-side end region of the toner image carried on the image bearing member with respect to the rotational direction of the image bearing member, and then a voltage of an opposite polarity to the charge polarity of the toner is applied to the rotatable transfer member.

Abstract: By using an antisense nucleotide, a ribozyme, a maxizyme, or an RNAi constructed based on the nucleotide sequence of exon 1 beta of the PDGF receptor alpha gene, which is expressed in specific cancer cells, or a polypeptide containing a portion thereof, translation of an mRNA transcribed from exon 1 beta of the PDGF receptor alpha gene is suppressed. An agent for suppressing expression containing as an active ingredient a substance for inhibiting expression, such as an antisense nucleotide, a ribozyme, a maxizyme, or an RNAi, is effective as a therapeutic agent for cancer.